Higher marketing and advertising spends, along with a drop in the share of the revenue from Covid-19 and allied tests, is estimated to have impacted operating profitability by 3-4 per cent in the first half of this fiscal: Shounak Chakravarty, associate director, Crisil.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/d4fKHy2
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» Diagnostic cos revenues to decline 7 per cent in FY23 amid fall in Covid tests: Crisil Ratings
https://ift.tt/0d4WtNw
No comments:
Post a Comment